Odyssey Health (ODYY) Long-Term Investments (2017 - 2025)
Odyssey Health (ODYY) reported Long-Term Investments of $97149.0 for Q2 2025, down 99.28% year-over-year from $13.4 million in Q2 2024, and down 38.71% sequentially from $158505.0 in Q1 2025.
Odyssey Health (ODYY) Long-Term Investments (2017 - 2025) Analysis & Trends
Odyssey Health has disclosed Long-Term Investments across 3 years of filings, most recently posting $97149.0 for Q2 2025.
- Quarterly Long-Term Investments fell 99.28% year-over-year to $97149.0 in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $97149.0 (down 99.28% YoY) and the FY2024 annual result came in at $529203.0, changed N/A from the prior year.
- Long-Term Investments fell to $97149.0 in Q2 2025, from $158505.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $13.8 million in Q1 2024 and bottomed at $97149.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 97,149.00 |
| Jan 31, 2025 | 158,505.00 |
| Oct 31, 2024 | 158,505.00 |
| Jul 31, 2024 | 529,203.00 |
| Apr 30, 2024 | 13.42 Mn |
| Jan 31, 2024 | 13.79 Mn |
| Oct 31, 2017 | 130,395.00 |
| Jul 31, 2017 | 107,157.00 |